BIOA Bioage Labs8.38+2.33 (+38.5%)
After Hours Decliner
BIOA Bioage Labs20.09+1.72+9.4%
After Hours:6.60-13.49 (-67.2%)
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity
Globe NewswireFri, 6-Dec 4:35 PM
After Hours:6.40-13.69 (-68.1%)
